Nucleotide signaling molecules are important messengers in key pathways that allow cellular responses to changing environments. Canonical secondary signaling molecules act through specific receptor proteins by direct binding to alter their activity. Cyclic diadenosine monophosphate (c-di-AMP) is an essential signaling molecule in bacteria that has only recently been discovered. Here, we report on the identification of four Staphylococcus aureus cdi-AMP receptor proteins that are also widely distributed among other bacteria. Using an affinity pull-down assay, we identified the potassium transporter-gating component KtrA as c-di-AMP receptor protein and it was further shown that this protein, together with c-di-AMP, enables S. aureus to grow in low potassium conditions. We defined the c-di-AMP binding activity within KtrA to the RCK C (regulator of conductance of K+) domain. This domain is also found in a second S. aureus protein, CpaA, which as we show here also directly binds c-di-AMP. Since RCK C domains are found in proteinaceous channels, transporters and antiporters from all kingdoms of life, these findings have broad implications for the regulation of different pathways through nucleotide-dependent signaling. Using a genome-wide nucleotide protein interaction screen, we further identified the histidine kinase protein KdpD that in many bacteria is also involved in the regulation of potassium transport and a PII-like signal transduction protein, which we renamed PstA, as c-di-AMP binding proteins. With the identification of these widely distributed c-di-AMP receptor proteins we link the c-di-AMP signaling network to a central metabolic process in bacteria.
Introduction. Nucleotide signaling molecules control fundamental processes in all forms of life. There is now a large body of evidence linking nucleotides such as cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP) and guanosine tetra-(ppGpp) and pentaphosphate (pppGpp) to the control of fundamental metabolic pathways and stress response processes in eukaryotic and prokaryotic cells (1) (2) (3) . Cyclicdinucleotides in particular have recently gained increased attention with the identification of novel nucleotides such as cyclic diadenosine monophosphate (c-di-AMP) and the hybrid c-AMP-GMP molecule in bacterial cells (4) (5) (6) , as well as the discovery that cyclic dinucleotides are also produced by eukaryotic cells (7) (8) (9) . The dinucleotide cyclic diguanosine monophosphate (c-di-GMP) and the molecular mechanisms by which it controls cellular pathways has been well characterized and it is now recognized as a central regulator in bacterial cells that controls the switch from free-living planktonic to a sessile biofilm-associated lifestyles. In pathogenic organisms this is often linked to colonization of the human host and virulence (10) . On the other hand, the function and the pathways controlled by the novel signaling nucleotide cdi-AMP are less clear, largely due to a gap in our knowledge of specific receptor proteins.
Many Gram-positive bacteria, including the important human pathogens Staphylococcus aureus (11) , Streptococcus pyogenes (12) , Listeria monocytogenes (5) and Mycobacterium tuberculosis (13) produce c-di-AMP and it is likely that c-di-AMP is also synthesized by several Gram-negative bacteria and a subset of archaea (14) . c-di-AMP is synthesized by DisA N domaincontaining proteins DacA, DisA and YojJ and degraded by the DHH/ DHHA1 domain-containing phosphodiesterase enzyme GdpP (4, 5, 11, (15) (16) (17) (18) . A variety of different phenotypes have been linked to altered c-di-AMP levels; an increase in c-di-AMP levels correlates with increased acid resistance (16, 19) and altered antibiotic resistance including an increase in methicillin resistance in S. aureus (11, 18, 20) . Most notable, however, are the findings that L. monocytogenes (5) and Bacillus subtilis (18) cannot grow in the absence of c-di-AMP, showing that in contrast to other signaling nucleotides, c-di-AMP controls essential cellular pathways. The molecular basis for this is currently not known, though it is assumed that, similar to other signalling molecules, c-di-AMP interacts with a specific set of target proteins and upon binding alters their activity or function. Currently only one bacterial c-di-AMP receptor protein, the TetR-type transcription factor DarR, has been identified in Mycobacterium smegmatis (21) . However, the absence of close DarR homologs in many organisms that likely produce c-di-AMP implies that additional c-di-AMP target proteins must exist.
In this study we have identified KtrA as c-di-AMP target protein by using an affinity pull down assay. KtrA is a member of the widely distributed RCK (regulator of conductance of K + ) protein family, known to be involved in the gating of ion channels. Here we show that KtrA is required for the growth of S. aureus under potassium limiting conditions. Through subsequent binding studies we show that c-di-AMP specifically interacts with the C-terminal RCK C domain of KtrA. A second S. aureus RCK C domain-containing protein CpaA, a predicted cation/proton antiporter, was subsequently identified bioinformatically and its interaction with c-di-AMP confirmed experimentally. Lastly, using a genome wide interaction screen, we identified the PII-like signal transduction protein PstA and the histidine kinase KdpD as additional c-di-AMP binding proteins. With the identification of these four novel and widely distributed c-di-AMP binding proteins we provide a link between c-di-AMP and a fundamental cellular process in bacteria, namely ion transport. assay using c-di-AMP-coupled magnetic beads and protein extracts derived from the S. aureus strain LAC*. This strain is an erythromycin sensitive derivative of the clinically relevant community-acquired methicillin resistant USA300 strain LAC. One protein band was enriched in samples obtained from cdi-AMP-coupled beads (Fig. 1A) and identified by mass spectrometry as S. aureus protein SAUSA300 0988. This protein has high similarity to the B. subtilis proteins KtrA BS (51% identity) and KtrC BS (63% identity) that together with their respective membrane components KtrB and KtrD, form potassium transporters ( Fig. 1B) (22) . SAUSA300 0988 is the only KtrA/C-type protein in S. aureus and was renamed KtrA SA . The cytoplasmic components of Ktr-systems are part of the RCK (regulator of conductance of K + ) protein family and play an important role in transporter gating (23, 24) . KtrA SA is a typical RCK protein with an RCK N domain and an RCK C domain (Fig. 1C) . Based on a structural model, it is likely that KtrA SA assumes a similar twolobed fold as the RCK domain in the potassium channel protein MthK of Methanobacterium thermoautotrophicus (Fig. S1) (25, 26) . Interestingly, a nucleotide-binding site for ATP and other nucleotides has been identified previously in the RCK N domain of the B. subtilis protein KtrA (23) and based on a structural model the RCK N domain of the S. aureus protein is likely to assume the same fold with the conserved GxGxxG motif forming part of a nucleotide-binding site and with aspartic acid residues D32 and D52 acting as crucial nucleotide-binding residues (Fig.  S1 ) (23) .
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c-di-AMP binds to the RCK C domain of KtrA. To confirm the interaction between KtrA SA and c-di-AMP and to define more precisely the interaction domain, we adapted the differential radial capillary action of ligand assay (DRaCALA), which was previously used to study c-di-GMP-protein interactions (27) . This assay is based on the principle that free nucleotides migrate outward when spotted on nitrocellulose membranes, whereas bound ligand is sequestered to the protein and immobilized in a tight spot on the membrane (Fig. 2A) . The distribution of free and bound ligand can be readily visualized and quantified using radiolabeled nucleotides. To determine if c-di-AMP-protein interactions could be measured with this assay, we produced 32 P-labeled c-di-AMP (Fig. S2 ) and tested its interaction with purified S. aureus GdpP and B. subtilis DisA proteins, c-di-AMP degrading and synthesizing enzymes, respectively. c-di-AMP-specific binding to these control proteins was observed (Fig. S3) , thus validating DRaCALA as a method to study c-di-AMP-protein interactions. Using this method, we next investigated the interaction between c-di-AMP and purified His-KtrA SA protein and determined an interaction with a K d of 64.4 ± 3.4 nM (Fig. 2B) . Only an excess of unlabeled c-di-AMP, but not the other nucleotides tested, including ATP, competed for binding with labeled c-di-AMP (Fig. 2C ). This also indicated that c-di-AMP does not bind to the previously described nucleotide-binding site in RCK N. Furthermore, c-di-AMP bound to the KtrA SA -D32A/D52A variant with alanine substitutions of the two key nucleotide-binding residues within RCK N (Fig. 2D ). To determine more specifically which portion of KtrA SA interacts with c-di-AMP, the RCK N and RCK C domains were produced and purified separately. While the RCK N domain interacted, as expected, with ATP it did not bind c-di-AMP (Fig. 2E ). In contrast, the RCK C domain bound c-di-AMP with a K d of 369.0 ± 44.4 nM ( Fig. 2E and 2F ), thus showing that the RCK C domain is the receptor domain of c-di-AMP. To further validate the DRaCALA binding results, an interaction between c-di-AMP and KtrA or the RCK C domain in the nM range was further confirmed by equilibrium dialysis (Fig. S4 ). Of note, a specific interaction between c-di-AMP and the RCK C domain of KtrA was also obtained when DRaCALAs were performed using Escherichia coli extracts prepared from strains producing different KtrA SA variants in place of purified proteins ( KtrA is important for the growth of S. aureus in low potassium. To investigate the involvement of KtrA SA and c-di-AMP in the growth of S. aureus in low potassium conditions, the growth of ktrA and gdpP mutant strains was compared to that of the wildtype LAC* strain. The gdpP mutant strain has 15-fold higher levels of intracellular c-di-AMP (11) and therefore KtrA should be in the nucleotide-bound state under these conditions. Since potassium uptake is especially important during osmotic stress, the different S. aureus strains were grown on chemically defined medium (CDM) plates containing 0.75 M NaCl. Under these stress condition, a two to three log growth defect was observed for both the ktrA and gdpP mutant strains, which could be complemented either by the addition of potassium or by the introduction of a functional copy of ktrA or gdpP, respectively ( Fig. 3A and 3B). The ktrA mutant was also hyper-susceptible to the potassium ionophore nigericin, which causes an exchange of intracellular K + for extracellular H + (Fig. 3C ). The hypersensitivity to nigericin could again be rescued by the addition of 250 mM potassium or by genetic complementation ( Fig. 3C and 3D ). Similarly a ktrA mutant strain in the methicillin sensitive S. aureus strain background Newman was also more sensitive to nigericin and did not grow as well as the wild-type strain under the osmotic stress conditions unless potassium was added (Fig. S6) . These results suggest a function for KtrA SA in potassium uptake in S. aureus strains and that c-di-AMP binding to KtrA SA might inactivate   137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202 channel activity, as the gdpP mutant strain, which has greatly increased levels of c-di-AMP, displays a phenotype similar to the ktrA mutant.
c-di-AMP interacts with CpaA, a second S. aureus RCK C domain-containing protein. The identification of the RCK C domain as a c-di-AMP interacting domain allows the bioinformatic prediction of other receptor proteins based on the presence of an RCK C domain. In this manner we discovered the protein SAUSA300 0911 in S. aureus strain LAC*, which we rename CpaA. This protein is a predicted cation/proton antiporter that is composed of an N-terminal transmembrane region followed by an RCK domain (Fig. 4A ). An interaction between its RCK C domain and c-di-AMP was tested by performing DRaCALAs with E. coli extracts prepared from strains either containing the empty vector as a control, or expressing the complete RCK or the RCK C domain of CpaA.
32 P-labeled c-di-AMP interacted specifically with both the RCK and the RCK C domain (Fig. 4B) , thus showing that CpaA is a second c-di-AMP target protein.
Identification of PstA and KdpD as specific di-AMP binding proteins using a genome-wide open reading frame (ORFeome) DRaCALA screen. The DRaCALA method can be used to identify nucleotide/protein interactions using crude whole-cell E. coli lysates. This makes this assay ideally suited to perform a genomewide protein/nucleotide interaction screen. An S. aureus strain 273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339 341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408 Submission PDF COL ORFeome Gateway library is available and we reasoned that this library together with the DRaCALA method should allow us to identify additional S. aureus c-di-AMP binding proteins. The library contains 2,343 S. aureus ORFs (86% of all S. aureus COL genes) within the Gateway entry vector pDONR221. These ORFs were recombined into the pDEST17 protein expression vector, placing each ORF under the control of the IPTGinducible T7 promoter. With the exception of eight reactions that failed, all other resulting plasmids were recovered in the E. coli protein expression strain T7IQ. Four percent of the library strains were subsequently analysed by PCR and all found to contain an insert of the expected size. Next, protein expression was induced and whole cell E. coli extracts prepared. Eight percent of these extracts were analyzed by SDS-PAGE and coomassie staining and visible protein overproduction was observed for approximately 70% of the lysates. Finally, these extracts, arrayed in twenty five 96-well plates, were used in DRaCALAs and the fraction of bound radiolabeled c-di-AMP determined for each spot. An average fraction bound value was determined for each plate and the cut off value for positive interactions was set at 1.4 times this average fraction bound background value. Extracts derived from strains expressing four different proteins gave c-di-AMP fraction bound values above background using these criteria, one of which was KtrA, thereby validating the DRaCALA ORFeome screen. The other positive clones, SACOL0525, SACOL2070 and SACOL2218, were confirmed by sequencing and renamed PstA (PII-like signal transduction protein A), KdpD (a sensor histidine kinase and annotated as KdpD in other S. aureus strains) and Adk (adenylate kinase), respectively. To determine if these proteins are indeed bona fide c-di-AMP binding proteins, the corresponding genes were reamplified from S. aureus LAC* chromosomal DNA and cloned into the E. coli expression vector pET28b for overproduction as His-tag fusion proteins. Subsequently, extracts were prepared and used in DRaCALAs (Fig. S7) . Of note, while the fraction bound values for PstA and KdpD were twice as high as the background value in the initial whole genome screen, the c-di-AMP fraction bound value obtained for Adk was only 1.45 times above background and so only just made the cut off ( Fig. 5A and S7 ). When no interaction was observed with Adk after recloning, this protein was no longer regarded as a c-di-AMP receptor protein (Fig S7) . On the other hand, c-di-AMP binding to PstA and KdpD was confirmed after recloning ( Fig.  S7 ) and both proteins interacted specifically with c-di-AMP as only the addition of an excess of cold c-di-AMP and not other cold nucleotides prevented the binding of radiolabeled c-di-AMP ( Fig. 5B and 5C ). CpaA was not identified in this screen as the gene encoding for this protein is not present in the S. aureus COL genome. Taken together, the genome-wide DRaCALA screen identified two additional S. aureus proteins, PstA and KdpD, as novel c-di-AMP receptor proteins.
Discussion
Since the discovery of c-di-AMP, it has been speculated that this nucleotide binds to proteins to regulate their function. In this study we identified four c-di-AMP receptor proteins, namely KtrA, CpaA, KdpD and PstA by using an affinity pull down assay, bioinformatics analysis and a genome-wide protein nucleotide interaction screen (Figs. 1, 4 and 5) . With the identification of three proteins (KtrA, CpaA, and KdpD) that have been implicated in potassium transport in other bacteria, we have linked c-di-AMP signaling to potassium transport in S. aureus. Interestingly, this distinguishes c-di-AMP from c-di-GMP, which regulates multiple cellular processes that help bacteria to transition between different lifestyles, such as extracellular carbohydrate and adhesion production, motility and biofilm formation. The link between cdi-AMP and the ion transport may explain why c-di-AMP, in contrast to other related signaling nucleotides, is essential for growth in bacterial species. Individually ktrA, cpaA, pstA and kdpD are not essential (28) (29) (30) however it is plausible that combined mutations may be lethal. Alternatively the existence of an as yet unidentified essential c-di-AMP receptor is also entirely possible.
The c-di-AMP binding region in S. aureus KtrA and CpaA was narrowed down to the RCK C domain (Figs. 2 and 4) . This domain is present in a large number of bacterial and archaeal proteins and there is a good correlation between the distribution of the c-di-AMP cyclase domain DisA N and the presence of RCK C domains. Most bacteria and archaea that potentially synthesize c-di-AMP also contain one or more proteins with an RCK C domain. This raises the possibility that c-di-AMP may contribute to the regulation of ion transport in a large number of bacteria and archaea. The number of RCK C domains per organism usually exceeds the number of cyclases, perhaps suggesting that c-di-AMP regulates the function of multiple proteins, which is similar to what we found in S. aureus. However, the RCK C domain is phylogenetically more widely distributed than the c-di-AMP cyclase domain and is also found in some eukaryotes such as green algae, in additional archaeal species and most notably in a large number of Gram-negative proteobacteria where the c-di-AMP cyclase domain is absent. We would predict that in those organisms other small molecules interact with this domain to regulate transport processes. The RCK C domain is associated Submission PDF 32 P-labeled c-di-AMP was dispensed into 96-well plates containing E. coli lysates and aliquots were subsequently spotted in duplicate onto nitrocellulose membrane. The fraction of bound c-di-AMP was calculated for each well as described in Roelofs et al. (27) and the average values from the duplicate spots plotted. Plates 5, 11 and 25 with positive interactions are shown. The average fraction bound value for plate 5 was 0.178 ± 0.029. Well A10 was spiked with a KtrA lysate and well E3 contained the PstA lysate, which had a fraction bound value of 0.370 (2 x background). The average fraction bound value for plate 11 was 0.174 ± 0.032. Well B12 was spiked with a KtrA lysate and well G11 contained the Adk lysate, which had a fraction bound value of 0.253 (1.45 x background). The average fraction bound value for plate 25 was 0.122 ± 0.015. Well G2 contained the KdpD lysate, with a fraction bound value of 0.252 (2 x background). (B and C) DRaCALAs were preformed with E. coli extracts prepared from strains overproducing His-PstA (B) or KdpD-His (C) and 32 P-labeled c-di-AMP and an excess of cold competitor nucleotide as indicated above each spot. Fraction of bound nucleotide was determined as described in Roelofs et al. (27) and values from three independent experiments were plotted with standard deviations.
as a soluble domain with potassium transporters, or in some cases directly linked to ion antiporters, such as in CpaA. However, this domain is also associated with predicted amino acid antiporters, citrate transporters and voltage-gated channels. This suggests that c-di-AMP or other small molecules might regulate a range of different transport processes, which have not been previously associated with signaling networks.
Potassium is a major and essential intracellular ion and therefore bacteria have evolved several different types of uptake systems. The third c-di-AMP binding protein identified in this study was KdpD, which is a widely distributed membrane embedded sensor histidine kinase that in many bacteria controls, together with its cognate response regulator KdpE, the expression of a second type of potassium uptake system. This ATP-dependent potassium uptake system has been best characterized in E. coli and consists of four membrane components KdpABCF and the two-component system KdpDE, which is required for KdpABCF expression at a very low potassium concentration when the other uptake systems are no longer sufficient to allow the cell to acquire the necessary amount of ion (31) . However, a recent study on the S. aureus KdpDE system suggested that this two-component system has a different function in this organism (32) . The S. aureus KdpDE two-component system, which still responds to the extracellular potassium concentration, was found to be no longer required for bacterial survival under low potassium conditions, but instead to control the expression of several well-characterized S. aureus virulence factors (32) . However, additional work is needed to fully understand the function of this two-component system in S. aureus and other Gram-positive bacteria and based on this study its interplay with cellular c-di-AMP levels.
The least characterized c-di-AMP receptor protein identified in this study is the DUF970 domain-containing PII-like signal transduction protein, which belongs to the GlnB superfamily of proteins and was renamed PstA. PII-type proteins are one of the most widely distributed signal transduction proteins in nature that are present in bacteria as well as archea and plants. DUF970 domain-containing PII-like proteins are not only present in Staphylococcus species but widely distributed among Firmicutes. Characterized proteins belonging to this GlnB superfamily are the cation tolerance protein CutA1 (33) and the ATP phosphoribosyltransferase HisG, the first enzyme of the histidine pathway (34) . However the best characterized proteins belonging to the GlnB superfamily are PII nitrogen regulatory proteins, which are key signal transduction protein that report on the nitrogen and carbon status of cells by sensing glutamine and 2-ketoglutarate levels (35) . Since proteins belonging to this superfamily are known to bind diverse ligands and function by protein-protein interaction to control the activity of enzymes, transcription factor or transport proteins, we would assume that upon c-di-AMP binding or release the S. aureus PstA protein interacts with other cellular proteins. However these still need to be discovered.
This work demonstrates the feasibility of a DRaCALA-based ORFeome screen as a high-throughput platform for identifying c-di-AMP receptor proteins. While the DRaCALA ORFeome screen will identify receptors whose binding site does not require additional proteins, biochemical pull-down assays will only yield receptors that are expressed in the assayed growth conditions. Together the combination of biochemical pull-down assays, bioinformatic analysis and systematic screening of a whole genome protein expression library by DRaCALA provides a powerful synergistic approach for the systematic elucidation of proteinmetabolite interaction networks (36) . The discovery of the four different and widely distributed c-di-AMP receptor proteins allows future research to determine the molecular mechanisms underlying c-di-AMP dependent processes in prokaryotes.
Methods
Bacterial strains and culture conditions. E. coli strains were grown in LB or LB-M9 (37), B. subtilis strains in LB and S. aureus strains in TSB or chemically defined medium (CDM) at 37°C with aeration. CDM was prepared as referenced (38) , with the following modifications: KH 2 PO 4 was substituted with Na Phosphate buffer and KCl was added at concentrations stated in the text. Affinity-pull down assay. 20 ml of an S. aureus LAC* culture with an OD 600 of 1 was harvested and suspended in 1 ml 10 mM Tris HCl pH 7.5, 50 mM NaCl buffer containing EDTA-free complete protease inhibitor (Roche). Cells were mixed with 0.1 mm glass beads and lysed in a Fast-Prep machine twice for 45 sec. at setting 6 (MP Biomedicals). Samples were centrifuged for 5 min at 17,000 x g and subsequently for 1 h at 100,000 x g to obtain cytoplasmic Submission PDF protein extracts. 40 l streptavidin dynabeads (Invitrogen) coupled with 2.4 M biotinylated c-di-AMP (BioLog) were incubated with 1.2 mg cytoplasmic proteins in 1.5 ml 10% glycerol, 1 mM MgCl 2 , 5 mM Tris pH 7.5, 230 mM NaCl, 0.5 mM DTT, 4 mM EDTA containing 50 g/ml BSA for 30 min at room temperature. Samples were washed 4 times with the same buffer lacking BSA and suspended in 50 l protein sample buffer. Samples were boiled for 5 min, beads removed and 18 l run on 12% SDS-PAGE gels. Gels were stained using the SilverQuest kit (Invitrogen). Mass spectrometry was performed at the Taplin Mass Spectrometry Facility (Harvard Medical School).
Protein purifications. Proteins were purified from 0.5-4 L E. coli cultures. Cultures were grown to an OD 600 0.5-0.7, protein expression induced with 0.5 mM IPTG and incubated overnight at 16 o C. Protein purifications were performed by nickel affinity and size exclusion chromatography as previously described (11, 39) . Protein concentrations were determined by A 280 readings.
Minimum Inhibitory Concentrations. Overnight cultures of S. aureus strains in CDM containing 2.5 mM KCl were adjusted to 5 x 10 5 bacteria/ml in CDM supplemented with either 2.5 or 250 mM KCl. 100 l of these suspensions were incubated in 96 well plates with 2-fold dilutions of nigericin starting at 6.25 M. Plates were incubated at 37°C with shaking for 24 h. MICs were determined as the antimicrobial concentration at which growth was inhibited by >75% compared to growth without antimicrobial. Five independent experiments were performed and one representative graph is shown.
Bacterial Stress Testing. Overnight cultures of S. aureus strains in CDM containing 2.5 mM KCl were washed three times in CDM lacking K + . Cultures were adjusted to an OD 600 of 0.05, serially diluted and 5 l spotted onto CDM agar plates containing an extra 0.75 M NaCl. Plates were incubated at 37°C for 24-36 h.
Construction of the S. aureus ORFeome expression library. 2,343 E. coli strains containing pDONR221 vectors with S. aureus strain COL ORFs (BEI Resources, NIAID, NIH) were grown in 1.5 ml LB-M9 in 2 ml 96-well deep dishes (Greiner) selecting for kanamycin resistance. The cultures were centrifuged and the plasmids extracted using 96-well MultiScreen HTS PLASMID plates (Millipore). The S. aureus gateway ORFeome library was shuttled from the pDONR221 entry plasmids into the protein overexpression destination vector pDEST17 using LR clonase enzyme II as per manufacturer s guidelines (Invitrogen). Subsequently, the destination plasmid library was introduced into E. coli strain T7IQ (NEB) selecting for carbenicillin resistance.
Preparation of E. coli whole cell lysates. BL21(DE3) pET28b-containing strains or T7IQ pDEST17 containing library expression strains were grown in LB-M9 medium overnight at 30°C and subsequently induced for 6 h with 1 mM IPTG for protein induction. Bacteria were collected by centrifugation and suspended in 1/10 th of their original volume in 40 mM Tris pH 7.5, 100 mM NaCl, 10 mM MgCl 2 binding buffer containing 2 mM PMSF, 20 g/ml DNase and 0.5 mg/ml lysozyme. Cells were lysed by 3 freeze/thaw cycles. Lysates were directly used in binding assays or stored at -20 o C. Differential radial capillary action of ligand assay (DRaCALA). The principle of the DRaCALA is described in Roelofs et al (27) . Briefly, E. coli wholecell lysates, 20 M purified protein (for standard assays) or 12.5 M protein (for competition assays) in binding buffer were mixed with approximately 1 nM 32 P-labeled c-di-AMP, synthesized as described in the supplementary information section, or 5.5 nM 32 P-labeled ATP and incubated at room temperature for 5 min. For the whole genome screen the 32 P-labeled c-di-AMP was dispensed into lysate-containing 96 well plates using a Multiflo Microplate Dispenser (BioTek) and the mixture spotted onto nitrocellulose membrane using a 96 well pin tool (V&P Scientific). For competition assays, 100 or 400 M cold nucleotides (ATP, GTP, cAMP, cGMP, NAD, NADH, NADP, NADPH; Sigma. c-di-AMP, c-di-GMP; BioLog) were added to the initial mixture and 2.5 l of reactions were spotted onto nitrocellulose membranes (Amersham Hybond-ECL; GE Healthcare), air-dried and radioactivity signals detected as described above. The fraction of ligand bound and K d values were calculated as previously described (27) .
